Britanin alleviates myocardial damage in rats with acute myocardial infarction by inhibiting the JAK۲/STAT۳ signaling pathway

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 13

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-29-11_010

تاریخ نمایه سازی: 22 آبان 1405

چکیده مقاله:

Objective(s): Acute myocardial infarction (AMI) is a life-threatening condition featuring coronary occlusion-induced myocardial ischemia-hypoxia, followed by tissue damage driven by calcium overload, inflammation, and pyroptosis. Current therapies offer limited myocardial protection. Britanin, a sesquiterpene lactone from Inula lineariifolia, has anti-inflammatory and antioxidant properties, while its role in AMI remains unclear. This study explored Britanin’s therapeutic effects on rat AMI and underlying mechanisms, focusing on the JAK۲/STAT۳ signaling pathway.Materials and Methods: Network pharmacology, molecular docking, and ProTox۳.۰ toxicity prediction were used for target screening and safety evaluation. Rat AMI models were established by left anterior descending ligation and treated with Britanin (۵/۱۰ mg/kg). Echocardiography, serum biochemistry, histopathological staining, Western blotting, and qPCR were used to assess cardiac function, myocardial injury, fibrosis, and molecular changes.Results: Pharmacology identified ۳۰ overlapping targets, including JAK۲, and highlighted JAK۲/STAT۳ as a key pathway. Britanin bound JAK۲ strongly (binding energy <-۸.۲ kcal/mol); its LD۵۰ was ۱۵۰ mg/kg, indicating safety. Britanin improved cardiac function indices, alleviated myocardial fibrosis, reduced serum injury markers, and down-regulated components of the JAK۲/STAT۳ pathway, the NLRP۳ (NOD-like receptor pyrin domain-containing ۳) inflammasome, and pyroptosis markers (all P<۰.۰۵), without liver or kidney toxicity.Conclusion: Britanin alleviates AMI-induced myocardial damage in rats by improving cardiac function, reducing injury and fibrosis, and inhibiting inflammation and pyroptosis through suppression of the JAK۲/STAT۳ pathway, positioning it as a potential AMI therapeutic agent.

نویسندگان

- -

Department of Cardiology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou City, Jiangsu Province, P. R. China

- -

Department of Cardiology, The Fourth Affiliated Hospital of Soochow University, Medical Center of Soochow University, Suzhou Dushu Lake Hospital, Suzhou City, Jiangsu Province, P. R. China

- -

Department of Cardiology, The Fourth Affiliated Hospital of Soochow University, Medical Center of Soochow University, Suzhou Dushu Lake Hospital, Suzhou City, Jiangsu Province, P. R. China

- -

Department of Physiology and Neurosciences, Medical College of Soochow University, Suzhou City, Jiangsu Province, P. R. China

- -

Department of Cardiology, The Fourth Affiliated Hospital of Soochow University, Medical Center of Soochow University, Suzhou Dushu Lake Hospital, Suzhou City, Jiangsu Province, P. R. China

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Saito Y, Oyama K, Tsujita K, Yasuda S, Kobayashi Y. ...
  • Ozaki Y, Hara H, Onuma Y, Katagiri Y, Amano T, ...
  • Michelucci E, Rocchiccioli S, Gaggini M, Ndreu R, Berti S, ...
  • Wang Y, Leifheit EC, Krumholz HM. Trends in ۱۰-Year outcomes ...
  • Udell JA, Bahit MC, Campbell P, Butler J, Chopra VK, ...
  • Luo L, Wang F, Xu X, Ma M, Kuang G, ...
  • Rao Z, Zhu Y, Yang P, Chen Z, Xia Y, ...
  • Kim HJ, Lee YS, Lee BS, Han CH, Kim SG, ...
  • Zhu H, Jian Z, Zhong Y, Ye Y, Zhang Y, ...
  • Bai Y, Li Z, Liu W, Gao D, Liu M, ...
  • Zhang Y, RuXian G. Didymin, a natural flavonoid, relieves the ...
  • Kajdanek A, Kolat D, Zhao LY, Kciuk M, Pasieka Z, ...
  • Shao JJ, Li WF, Sun JF, Zhuang ZS, Min JL, ...
  • Wu G, Zhu L, Yuan X, Chen H, Xiong R, ...
  • Hashmi S, Al-Salam S. Acute myocardial infarction and myocardial ischemia-reperfusion ...
  • Al-Salam S, Hashmi S. Myocardial ischemia reperfusion injury: Apoptotic, inflammatory ...
  • Ramachandran A, Jha S, Lefer DJ. Review paper: Pathophysiology of ...
  • Arumugam R, Srinadhu ES, Subramanian B, Nallani S. beta-PVDF based ...
  • Cooke JP, Youker KA, Lai L. Myocardial recovery versus myocardial ...
  • Chi C, Song K. Cellular reprogramming of fibroblasts in heart ...
  • Chen W, Bian W, Zhou Y, Zhang J. Cardiac Fibroblasts ...
  • Rathinavel A, Sankar J, Mohammed Sadullah SS, Niranjali Devaraj S. ...
  • Xu G, Zhao X, Fu J, Wang X. Resveratrol increases ...
  • Xu G, Ma Y, Jin J, Wang X. Activation of ...
  • Yao L, Chen H, Wu Q, Xie K. Hydrogen-rich saline ...
  • Fede MS, Daziani G, Tavoletta F, Montana A, Compagnucci P, ...
  • Shen S, Wang Z, Sun H, Ma L. Role of ...
  • Zhang Z, Venditti R, Ran L, Liu Z, Vivot K, ...
  • Wang F, Gao Q, Yang J, Wang C, Cao J, ...
  • Xu LJ, Chen RC, Ma XY, Zhu Y, Sun GB, ...
  • نمایش کامل مراجع